Literature DB >> 23391721

PAR-1 contributes to the innate immune response during viral infection.

Silvio Antoniak1, A Phillip Owens, Martin Baunacke, Julie C Williams, Rebecca D Lee, Alice Weithäuser, Patricia A Sheridan, Ronny Malz, James P Luyendyk, Denise A Esserman, JoAnn Trejo, Daniel Kirchhofer, Burns C Blaxall, Rafal Pawlinski, Melinda A Beck, Ursula Rauch, Nigel Mackman.   

Abstract

Coagulation is a host defense system that limits the spread of pathogens. Coagulation proteases, such as thrombin, also activate cells by cleaving PARs. In this study, we analyzed the role of PAR-1 in coxsackievirus B3-induced (CVB3-induced) myocarditis and influenza A infection. CVB3-infected Par1(-/-) mice expressed reduced levels of IFN-β and CXCL10 during the early phase of infection compared with Par1(+/+) mice that resulted in higher viral loads and cardiac injury at day 8 after infection. Inhibition of either tissue factor or thrombin in WT mice also significantly increased CVB3 levels in the heart and cardiac injury compared with controls. BM transplantation experiments demonstrated that PAR-1 in nonhematopoietic cells protected mice from CVB3 infection. Transgenic mice overexpressing PAR-1 in cardiomyocytes had reduced CVB3-induced myocarditis. We found that cooperative signaling between PAR-1 and TLR3 in mouse cardiac fibroblasts enhanced activation of p38 and induction of IFN-β and CXCL10 expression. Par1(-/-) mice also had decreased CXCL10 expression and increased viral levels in the lung after influenza A infection compared with Par1(+/+) mice. Our results indicate that the tissue factor/thrombin/PAR-1 pathway enhances IFN-β expression and contributes to the innate immune response during single-stranded RNA viral infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23391721      PMCID: PMC3582138          DOI: 10.1172/JCI66125

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  93 in total

Review 1.  Protease-activated receptors: novel PARtners in innate immunity.

Authors:  V Shpacovitch; M Feld; N W Bunnett; M Steinhoff
Journal:  Trends Immunol       Date:  2007-10-30       Impact factor: 16.687

Review 2.  Evolution and phylogeny of defense molecules associated with innate immunity in horseshoe crab.

Authors:  S Iwanaga; S Kawabata
Journal:  Front Biosci       Date:  1998-09-01

3.  Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin.

Authors:  A Phillip Owens; Freda H Passam; Silvio Antoniak; Stephanie M Marshall; Allison L McDaniel; Lawrence Rudel; Julie C Williams; Brian K Hubbard; Julie-Ann Dutton; Jianguo Wang; Peter S Tobias; Linda K Curtiss; Alan Daugherty; Daniel Kirchhofer; James P Luyendyk; Patrick M Moriarty; Shanmugam Nagarajan; Barbara C Furie; Bruce Furie; Douglas G Johns; Ryan E Temel; Nigel Mackman
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

4.  Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.

Authors:  S A Gregory; J H Morrissey; T S Edgington
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

5.  The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester.

Authors:  D C Crossman; D P Carr; E G Tuddenham; J D Pearson; J H McVey
Journal:  J Biol Chem       Date:  1990-06-15       Impact factor: 5.157

6.  PAR1 contributes to influenza A virus pathogenicity in mice.

Authors:  Khaled Khoufache; Fatma Berri; Wolfgang Nacken; Annette B Vogel; Marie Delenne; Eric Camerer; Shaun R Coughlin; Peter Carmeliet; Bruno Lina; Guus F Rimmelzwaan; Oliver Planz; Stephan Ludwig; Béatrice Riteau
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

7.  Crosstalk between coagulation and inflammation during Dengue virus infection.

Authors:  Alejandra Huerta-Zepeda; Carlos Cabello-Gutiérrez; Jorge Cime-Castillo; Verónica Monroy-Martínez; Maria Eugenia Manjarrez-Zavala; Margarita Gutiérrez-Rodríguez; Raúl Izaguirre; Blanca H Ruiz-Ordaz
Journal:  Thromb Haemost       Date:  2008-05       Impact factor: 5.249

8.  SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.

Authors:  Jennifer L Strande; Anna Hsu; Jidong Su; Xiangping Fu; Garrett J Gross; John E Baker
Journal:  Basic Res Cardiol       Date:  2007-04-30       Impact factor: 17.165

9.  Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus.

Authors:  Alexia G Smith; Patricia A Sheridan; Joyce B Harp; Melinda A Beck
Journal:  J Nutr       Date:  2007-05       Impact factor: 4.798

Review 10.  Fibrin and fibrinolysis in infection and host defense.

Authors:  J L Degen; T H Bugge; J D Goguen
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

View more
  64 in total

Review 1.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

2.  Roles of PAR1 and PAR2 in viral myocarditis.

Authors:  Nigel Mackman; Silvio Antoniak
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 3.  The procoagulant envelope virus surface: contribution to enhanced infection.

Authors:  Edward L G Pryzdial; Michael R Sutherland; Wolfram Ruf
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 4.  Multiple roles of the coagulation protease cascade during virus infection.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

5.  Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.

Authors:  Silvio Antoniak; Kohei Tatsumi; Clare M Schmedes; Steven P Grover; Rafal Pawlinski; Nigel Mackman
Journal:  J Mol Cell Cardiol       Date:  2018-08-10       Impact factor: 5.000

Review 6.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

7.  Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.

Authors:  Silvio Antoniak; Jessica C Cardenas; Laura J Buczek; Frank C Church; Nigel Mackman; Rafal Pawlinski
Journal:  Cardiology       Date:  2016-11-24       Impact factor: 1.869

Review 8.  Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.

Authors:  Fatma Berri; Vuong Ba Lê; Martine Jandrot-Perrus; Bruno Lina; Béatrice Riteau
Journal:  Cell Mol Life Sci       Date:  2013-10-04       Impact factor: 9.261

9.  Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12.

Authors:  Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Anna V Wojcicki; Jessica L Ray; Bradley P Sullivan; John E Froehlich; Brendan F Johnson; Matthew J Flick; James P Luyendyk
Journal:  J Hepatol       Date:  2016-12-10       Impact factor: 25.083

10.  Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.

Authors:  Silvio Antoniak; Kohei Tatsumi; Michael Bode; Swetha Vanja; Julie C Williams; Nigel Mackman
Journal:  J Innate Immun       Date:  2016-11-08       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.